Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre E Escargueil

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The Biochemical Journal|January 11, 2007
Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2AAlexandre E Escargueil, Annette K Larsen
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Perspective: plasticity, the enemy of the goodSarah Yvonnet, Anouk Barberousse, Alexandre E Escargueil
Cancers|April 30, 2021
Colorectal Cancer and Immunity: From the Wet Lab to IndividualsElodie Pramil, Clémentine Dillard, Alexandre E Escargueil
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2002
The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membraneAlexia Garrigues, Alexandre E Escargueil, Stephane Orlowski
Antiviral Research|August 7, 2023
Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivationChloé Borde, Alexandre E Escargueil, Vincent Maréchal
Pharmacology & Therapeutics|July 31, 2003
Catalytic topoisomerase II inhibitors in cancer therapyAnnette K Larsen, Alexandre E Escargueil, Andrzej Skladanowski
Progress in Cell Cycle Research|November 5, 2003
From DNA damage to G2 arrest: the many roles of topoisomerase IIAnnette K Larsen, Alexandre E Escargueil, Andrzej Skladanowski
Molecular Pharmacology|June 9, 2005
Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agentsAndrzej Skladanowski, Marie-George Côme, Michal Sabisz, et al.
Journal of Cell Science|February 6, 2004
Molecular cross-talk between the transcription, translation, and nonsense-mediated decay machineriesFrancisco J Iborra, Alexandre E Escargueil, Kon Y Kwek, et al.
Current Pharmaceutical Design|September 3, 2016
Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary BiologyAlexandre E Escargueil, Soizic Prado, Ambre Dezaire, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|January 11, 2007
Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2AAlexandre E Escargueil, Annette K Larsen
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Perspective: plasticity, the enemy of the goodSarah Yvonnet, Anouk Barberousse, Alexandre E Escargueil
Cancers|April 30, 2021
Colorectal Cancer and Immunity: From the Wet Lab to IndividualsElodie Pramil, Clémentine Dillard, Alexandre E Escargueil
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2002
The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membraneAlexia Garrigues, Alexandre E Escargueil, Stephane Orlowski
Antiviral Research|August 7, 2023
Shikonin, an inhibitor of inflammasomes, inhibits Epstein-Barr virus reactivationChloé Borde, Alexandre E Escargueil, Vincent Maréchal
Pharmacology & Therapeutics|July 31, 2003
Catalytic topoisomerase II inhibitors in cancer therapyAnnette K Larsen, Alexandre E Escargueil, Andrzej Skladanowski
Progress in Cell Cycle Research|November 5, 2003
From DNA damage to G2 arrest: the many roles of topoisomerase IIAnnette K Larsen, Alexandre E Escargueil, Andrzej Skladanowski
Molecular Pharmacology|June 9, 2005
Down-regulation of DNA topoisomerase IIalpha leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule-interacting agentsAndrzej Skladanowski, Marie-George Côme, Michal Sabisz, et al.
Journal of Cell Science|February 6, 2004
Molecular cross-talk between the transcription, translation, and nonsense-mediated decay machineriesFrancisco J Iborra, Alexandre E Escargueil, Kon Y Kwek, et al.
Current Pharmaceutical Design|September 3, 2016
Genotype- or Phenotype-Targeting Anticancer Therapies? Lessons from Tumor Evolutionary BiologyAlexandre E Escargueil, Soizic Prado, Ambre Dezaire, et al.
Pageof 4